Is Stem Cell Therapy Legal in Thailand? A 2026 Regulatory Guide

Cell therapy in Thailand is legal but regulated — not banned, and not a free-for-all. This guide explains who oversees it, what the 2024 decree changed, and how to tell whether a provider is operating inside the rules.

Regulatory guide to stem cell therapy in Thailand — Healthi Life, a doctor-led longevity house in Bangkok

Physician-led regenerative medicine at Healthi Life, The Urban Longevity House, Bangkok

Medically reviewed by Dr. Petch

International Board of Lifestyle Medicine (IBLM) — Diplomate

Last reviewed: July 11, 2026

Yes — stem cell therapy is legal in Thailand, but it is regulated rather than unrestricted. Oversight is shared by three authorities: the Thai FDA, the Medical Council of Thailand, and the Ministry of Public Health. A May 2024 decree separates minimal-manipulation procedures from Advanced Therapy Medicinal Products (ATMP), which face stricter manufacturing and registration rules. Any therapy must be delivered by a licensed physician in a licensed facility, after a documented medical assessment and informed consent.

Key Takeaways

Cell therapy is legal but regulated in Thailand — overseen jointly by the Thai FDA, the Medical Council of Thailand, and the Ministry of Public Health.
A 2024 regulatory update classifies products involving more than minimal manipulation as Advanced Therapy Medicinal Products (ATMP).
ATMPs require PIC/S-standard GMP manufacturing and Thai FDA product registration; minimal-manipulation procedures fall under Good Tissue Practice.
MSC, CAR-T, NK, dendritic, and iPS cell products typically fall in the ATMP category because they are more than minimally manipulated.
Every therapy requires a licensed physician, a licensed facility, a documented medical assessment, informed consent, and adverse-event reporting.

Who Regulates Cell Therapy in Thailand

Oversight of cell and stem cell therapy in Thailand is shared across three bodies, each with a distinct remit. Understanding the split explains why a compliant provider answers to more than one authority.

Thai FDA — regulates cell-based products themselves, including manufacturing standards and, for Advanced Therapy Medicinal Products, product registration.
Medical Council of Thailand — governs physician conduct and the ethics of clinical practice, including what may be offered and how it is described to patients.
Ministry of Public Health — licenses the medical establishments in which therapies are delivered.

The Medical Council's ethical regulation requires that clinical uses be evidence-based or conducted within ethics-committee-approved research. Presenting experimental therapy as proven is prohibited, and guarantees of outcome are not permitted. Together, these three authorities set the boundaries within which any legitimate cell therapy operates.

The 2024 Decree: Minimal Manipulation vs ATMP

The pivotal distinction in Thai regulation is how much a cell product is processed before use. A 2024 regulatory update formalized the line between minimally manipulated tissue and products that are more than minimally manipulated — the latter classed as Advanced Therapy Medicinal Products (ATMP). The category determines which standard applies.

Category	Definition	Examples	What the law requires
Minimal manipulation	Cells or tissue kept close to their natural state, without culture, expansion, genetic modification, or activation.	Hematopoietic (blood) cell transplantation, platelet-rich plasma (PRP), amniotic membrane.	Good Tissue Practice standards; delivery by a licensed physician in a licensed facility.
ATMP (more than minimal manipulation)	Products altered through cell culture, expansion, genetic modification, or activation.	Mesenchymal stem cells (MSCs), CAR-T, NK cells, dendritic cells, iPS-derived products.	PIC/S-standard GMP manufacturing plus Thai FDA product registration, in addition to physician and facility licensing.

The distinction is not a ranking of safety or value — it reflects how much a product has been processed and therefore how it is regulated. Because MSCs are typically expanded in culture, they generally sit in the ATMP category. Confirming the category of a specific protocol, and the standard it follows, is a question for the treating physician.

What This Means for Patients

The framework gives anyone considering cell therapy a practical checklist. These questions apply to any clinic, anywhere in Thailand — use them to confirm a provider is operating inside the rules rather than around them.

Licensed physician — care is directed by a physician licensed to practice in Thailand, not delegated to non-medical staff.
Licensed facility — the therapy is delivered in an establishment licensed by the Ministry of Public Health.
Assessment first — a documented medical assessment precedes any protocol; nothing is prescribed on request alone.
Informed consent — benefits, risks, and limits are explained clearly, in writing, before you proceed.
Sourcing and standard — the provider can explain how the cell product is manufactured and whether it follows Good Tissue Practice or GMP.
No guarantees — be cautious of guaranteed results or experimental therapy described as proven; both are prohibited under the Medical Council's rules.

If a provider cannot answer these plainly, that is itself an answer. Regulation exists to protect patients, and a compliant house treats these questions as routine.

How a Doctor-Led House Approaches This

At Healthi Life, every protocol begins with a physician assessment and consultation; eligibility and the appropriate pathway are determined case by case with the physician. Cell-based options sit within our Recovery & Performance medicine, where the first step is always evaluation — never a protocol on request.

For guests exploring their options, the starting point is a conversation, not a treatment. You can read more about our physician-led stem cell therapy programs, or bring your questions directly to a consultation, where the appropriate pathway is discussed against your own health and goals.

Physician-Led Regenerative Medicine at Healthi Life

Our stem cell therapy programs sit within Recovery & Performance medicine at Bangkok's longevity house — every pathway defined with a physician.

All programs begin with physician assessment. No protocol is prescribed without context. Precision interventions. Long-term strategies. No shortcuts.

References

This page is educational and does not constitute medical or legal advice. Regulatory details can change — confirm the current position with a licensed physician or the relevant authority.

Thai Food and Drug Administration (Thai FDA) — en.fda.moph.go.th (regulation of cell-based products and ATMP registration).
Medical Council of Thailand — tmc.or.th (physician conduct and ethical regulation of clinical practice).
The Nation Thailand — reporting on the 2024 regulatory update reclassifying advanced cell therapy products in Thailand: nationthailand.com.

Dr. Sarassawadee Suwanjinda (Dr. Petch)

Verified Physician

Co-Founder & Chief Medical Strategy Officer

International Board of Lifestyle Medicine (IBLM) Diplomate

Dr. Sarassawadee Suwanjinda (Dr. Petch) is Co-Founder & Chief Medical Strategy Officer at Healthi Life, an International Board of Lifestyle Medicine (IBLM) Diplomate. She leads the longevity programs — biological-age and biomarker-driven protocols designed and re-tested over time.

Longevity MedicineBiomarkersBiological AgeFunctional Medicine

View full profile →LinkedIn

Stem Cell Therapy Regulation in Thailand: Frequently Asked Questions

Is stem cell therapy legal in Thailand?

Yes. Cell therapy is legal in Thailand but regulated — it is not banned, and it is not unrestricted. Oversight is shared by three authorities: the Thai FDA, the Medical Council of Thailand, and the Ministry of Public Health. Since a 2024 regulatory update, products involving more than minimal manipulation of cells are classed as Advanced Therapy Medicinal Products (ATMP) and carry additional manufacturing and registration requirements. Any therapy must be delivered by a licensed physician in a licensed facility, after a documented medical assessment and informed consent.

What's the difference between minimal manipulation and ATMP?

The distinction turns on how much a cell product is processed. Minimal-manipulation procedures — for example hematopoietic cell transplantation, PRP, or amniotic membrane — keep the tissue close to its natural state and fall under Good Tissue Practice standards. Products that are more than minimally manipulated — through cell culture, expansion, genetic modification, or activation — are classed as Advanced Therapy Medicinal Products (ATMP). Under the May 2024 decree, ATMPs require PIC/S-standard GMP manufacturing and Thai FDA product registration. Which category a given protocol falls into is a clinical and regulatory question best confirmed with the treating physician.

Are MSC treatments regulated in Thailand?

Mesenchymal stem cells (MSCs) are typically expanded in culture, which is considered more than minimal manipulation. On that basis they generally fall within the ATMP category — alongside CAR-T, NK cells, dendritic cells, and iPS-derived products — and are subject to PIC/S GMP manufacturing and Thai FDA registration requirements. That does not make MSC therapy either automatically available or automatically prohibited; it means a defined regulatory pathway applies. The appropriate pathway for any individual is determined by the treating physician after a medical assessment, not by general information on a web page.

What should I check before choosing a clinic?

Confirm the essentials that the Thai framework requires of any provider: a licensed physician directing care, a facility licensed by the Ministry of Public Health, a documented medical assessment before any protocol, and clear informed consent that explains benefits, risks, and limits. Ask how the cell product is sourced and manufactured, and whether it follows the applicable Good Tissue Practice or GMP standard. Be cautious of guaranteed outcomes or experimental treatments presented as proven — the Medical Council's ethical rules prohibit both. When in doubt, ask the physician to explain the regulatory category of the specific protocol.

Is stem cell therapy safe?

Safety depends on the specific therapy, the individual, and the setting in which it is delivered — no cell therapy is risk-free, and outcomes are not guaranteed. Thailand's framework is designed to reduce risk by requiring a licensed physician, a licensed facility, a documented assessment, informed consent, and adverse-event reporting. Evidence varies widely between applications, and the Medical Council requires that uses be evidence-based or conducted within ethics-approved research. A candid risk-benefit discussion with a physician, specific to your health and goals, is the only reliable way to understand what a given protocol may or may not offer.

Do I need a doctor's assessment first?

Yes. Under Thailand's framework, a documented medical assessment by a licensed physician is a prerequisite for cell therapy, not an optional step. The assessment establishes whether a therapy is appropriate at all, which pathway applies, and what the realistic benefits, risks, and limits are for you specifically. At Healthi Life, every protocol begins with a physician assessment and consultation; eligibility and the appropriate pathway are determined case by case with the physician. No protocol is prescribed without that context.